Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

NCT06792786 is registered in ClinicalTrials.gov with The Central Hospital of Lishui City as lead sponsor.

NCT NCT06792786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06792786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring
Lead sponsor
The Central Hospital of Lishui City
Phase
Not applicable
Overall status
Recruiting
Start date
December 10, 2024
Completion date
December 30, 2027
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ctdna, esophageal cancer